Cryptococcal Meningitis News and Research

RSS
Cryptococcal meningitis is an infection of the lining of the brain and spinal cord. The fungus that causes this infection is found in soil. The risk is highest when CD4 cell counts are below 100. You can get it by breathing in dust. Symptoms include headache, nausea, fever, fatigue, irritability, sensitivity to light, stiff neck, change in mental state, and hallucinations.
Findings reveal a new way to prevent meningitis

Findings reveal a new way to prevent meningitis

Simple low-cost intervention could help reduce HIV-related deaths in Africa

Simple low-cost intervention could help reduce HIV-related deaths in Africa

Leading microbiologist warns of killer fungi’s increasing threat

Leading microbiologist warns of killer fungi’s increasing threat

Investigators isolate protein that is responsible for fungus' ability to cross blood-brain barrier

Investigators isolate protein that is responsible for fungus' ability to cross blood-brain barrier

Drug used for treating breast cancer also kills fungal disease

Drug used for treating breast cancer also kills fungal disease

Viamet initiates phase 2 clinical trial of antifungal agent VT-1161 for treatment of vulvovaginal candidiasis

Viamet initiates phase 2 clinical trial of antifungal agent VT-1161 for treatment of vulvovaginal candidiasis

Short-course amphotericin is cost-effective for cryptococcal meningitis

Short-course amphotericin is cost-effective for cryptococcal meningitis

University of Nevada researcher to optimize new rapid test for melioidosis

University of Nevada researcher to optimize new rapid test for melioidosis

ZOLOFT holds promise against cryptococcal meningitis

ZOLOFT holds promise against cryptococcal meningitis

Viamet commences VT-464 Phase 1/2 trial in castration-refractory prostate cancer

Viamet commences VT-464 Phase 1/2 trial in castration-refractory prostate cancer

Researchers to begin drug development projects for rare and neglected diseases

Researchers to begin drug development projects for rare and neglected diseases

Viamet commences VT-1161 Phase 1 clinical study to treat fungal infections

Viamet commences VT-1161 Phase 1 clinical study to treat fungal infections

IMMY, University of Nevada receive FDA clearance for CrAg Lateral Flow Assay

IMMY, University of Nevada receive FDA clearance for CrAg Lateral Flow Assay

NIH selects Viamet's novel antifungal compound for inclusion in the TRND program

NIH selects Viamet's novel antifungal compound for inclusion in the TRND program

New research sheds light on origins of cryptococcal fungal infection

New research sheds light on origins of cryptococcal fungal infection

IMMY, University of Nevada, Reno collaborate to make new blood test for Cryptococcosis

IMMY, University of Nevada, Reno collaborate to make new blood test for Cryptococcosis

AIDS patients with serum biomarkers are predisposed to immune reconstitution inflammatory syndrome

AIDS patients with serum biomarkers are predisposed to immune reconstitution inflammatory syndrome

Sagent Pharmaceuticals adds fluconazole injection to its line of premixed bags

Sagent Pharmaceuticals adds fluconazole injection to its line of premixed bags

Early retroviral use best for AIDS patients with serious complications

Early retroviral use best for AIDS patients with serious complications

Early use of antiretroviral treatment improves survival rate of HIV patients

Early use of antiretroviral treatment improves survival rate of HIV patients

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.